Historical record - last NADAC effective date: 4/22/2020

Product Information

NAPROXEN 250 MG TABLET is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $0.0574 per EA under NDC 53746018810. Its NADAC has been published 336 times since Nov 28, 2013.

FDA first approved this application on Dec 18, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

NAPROXEN 250 MG TABLET

Naproxen
$0.0574per EA

Strength

250 mg/1

NDC

53746018810

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

4/22/2020

Active Ingredients

NAPROXEN

Approval Type

Generic (ANDA)

FDA Application

ANDA075927

FDA Approved

12/18/2001

TE Code

AB

On Market Since

2/18/2010

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for NAPROXEN 250 MG TABLET has been published 336 times since Nov 28, 2013, and over the history we have for it it has risen 50.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0574 per EA
All-time high$0.0578 (Mar 13, 2019)
All-time low$0.0344 (Dec 17, 2014)
Median price$0.0488
Average price$0.0469
Largest weekly change+34.0% (Apr 22, 2015)
Weeks tracked336
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+50.4%

Last surveyed Apr 29, 2020 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 24% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of NAPROXEN 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for NAPROXEN 250 MG TABLET, manufactured by Amneal Pharmaceuticals of New York LLC, is $0.0574 per EA (NDC 53746018810), effective Apr 29, 2020.

How has the price of NAPROXEN 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for NAPROXEN 250 MG TABLET has risen 50.4%. It has been tracked across 336 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for NAPROXEN 250 MG TABLET?

Since Nov 28, 2013, the NADAC for NAPROXEN 250 MG TABLET has ranged from a low of $0.0344 (Dec 17, 2014) to a high of $0.0578 (Mar 13, 2019), with a median of $0.0488 per EA.

Are there cheaper alternatives to NAPROXEN 250 MG TABLET?

Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NAPROXEN 250 MG TABLET, is $0.0438 per EA — about 24% below NAPROXEN 250 MG TABLET.

Who manufactures NAPROXEN 250 MG TABLET?

NAPROXEN 250 MG TABLET (NDC 53746018810) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.